Search Results - (Author, Cooperation:D. Schadendorf)
-
1Fan, K., Ritter, C., Nghiem, P., Blom, A., Verhaegen, M. E., Dlugosz, A., Odum, N., Woetmann, A., Tothill, R. W., Hicks, R. J., Sand, M., Schrama, D., Schadendorf, D., Ugurel, S., Becker, J. C.
The American Association for Cancer Research (AACR)
Published 2018Staff ViewPublication Date: 2018-12-04Publisher: The American Association for Cancer Research (AACR)Print ISSN: 1078-0432Electronic ISSN: 1557-3265Topics: MedicinePublished by: -
2N. McGranahan ; A. J. Furness ; R. Rosenthal ; S. Ramskov ; R. Lyngaa ; S. K. Saini ; M. Jamal-Hanjani ; G. A. Wilson ; N. J. Birkbak ; C. T. Hiley ; T. B. Watkins ; S. Shafi ; N. Murugaesu ; R. Mitter ; A. U. Akarca ; J. Linares ; T. Marafioti ; J. Y. Henry ; E. M. Van Allen ; D. Miao ; B. Schilling ; D. Schadendorf ; L. A. Garraway ; V. Makarov ; N. A. Rizvi ; A. Snyder ; M. D. Hellmann ; T. Merghoub ; J. D. Wolchok ; S. A. Shukla ; C. J. Wu ; K. S. Peggs ; T. A. Chan ; S. R. Hadrup ; S. A. Quezada ; C. Swanton
American Association for the Advancement of Science (AAAS)
Published 2016Staff ViewPublication Date: 2016-03-05Publisher: American Association for the Advancement of Science (AAAS)Print ISSN: 0036-8075Electronic ISSN: 1095-9203Topics: BiologyChemistry and PharmacologyComputer ScienceMedicineNatural Sciences in GeneralPhysicsKeywords: Adenocarcinoma/drug therapy/genetics/*immunology ; Aged ; Aged, 80 and over ; Antigens, Neoplasm/genetics/*immunology ; Antineoplastic Agents/therapeutic use ; CD4-Positive T-Lymphocytes/*immunology ; CTLA-4 Antigen/immunology ; Carcinoma, Non-Small-Cell Lung/genetics/immunology ; Cell Cycle Checkpoints/immunology ; Female ; Humans ; *Immunologic Surveillance ; Lung Neoplasms/drug therapy/genetics/*immunology ; Lymphocytes, Tumor-Infiltrating/immunology ; Male ; Melanoma/immunology ; Middle Aged ; Mutation ; Programmed Cell Death 1 Receptor/immunology ; Skin Neoplasms/immunologyPublished by: -
3S. Horn ; A. Figl ; P. S. Rachakonda ; C. Fischer ; A. Sucker ; A. Gast ; S. Kadel ; I. Moll ; E. Nagore ; K. Hemminki ; D. Schadendorf ; R. Kumar
American Association for the Advancement of Science (AAAS)
Published 2013Staff ViewPublication Date: 2013-01-26Publisher: American Association for the Advancement of Science (AAAS)Print ISSN: 0036-8075Electronic ISSN: 1095-9203Topics: BiologyChemistry and PharmacologyComputer ScienceMedicineNatural Sciences in GeneralPhysicsKeywords: Binding Sites ; Cell Line, Tumor ; Female ; *Gene Expression Regulation, Neoplastic ; *Germ-Line Mutation ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Melanoma/*genetics/secondary ; Pedigree ; Polymorphism, Single Nucleotide ; *Promoter Regions, Genetic ; Proto-Oncogene Proteins c-ets/metabolism ; Sequence Analysis, DNA ; Skin Neoplasms/*genetics/pathology ; Telomerase/chemistry/*genetics/metabolism ; Transcription Initiation Site ; Transcription, Genetic ; ets-Domain Protein Elk-1/metabolism ; ets-Domain Protein Elk-4/metabolismPublished by: -
4E. M. Van Allen ; D. Miao ; B. Schilling ; S. A. Shukla ; C. Blank ; L. Zimmer ; A. Sucker ; U. Hillen ; M. H. Foppen ; S. M. Goldinger ; J. Utikal ; J. C. Hassel ; B. Weide ; K. C. Kaehler ; C. Loquai ; P. Mohr ; R. Gutzmer ; R. Dummer ; S. Gabriel ; C. J. Wu ; D. Schadendorf ; L. A. Garraway
American Association for the Advancement of Science (AAAS)
Published 2015Staff ViewPublication Date: 2015-09-12Publisher: American Association for the Advancement of Science (AAAS)Print ISSN: 0036-8075Electronic ISSN: 1095-9203Topics: BiologyChemistry and PharmacologyComputer ScienceMedicineNatural Sciences in GeneralPhysicsKeywords: Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/*pharmacology/therapeutic use ; Antigens, Neoplasm/*genetics ; *Biomarkers, Pharmacological ; CTLA-4 Antigen/*antagonists & inhibitors ; Cell Cycle Checkpoints/genetics/immunology ; Cohort Studies ; DNA Mutational Analysis ; Drug Resistance, Neoplasm/genetics ; Exome ; Female ; Genomics ; HLA Antigens/genetics ; Humans ; Male ; Melanoma/*drug therapy/*genetics/secondary ; Middle Aged ; Mutation ; Skin Neoplasms/*drug therapy/*genetics/pathology ; Tumor Microenvironment/drug effects/immunology ; Young AdultPublished by: -
5M. F. Berger ; E. Hodis ; T. P. Heffernan ; Y. L. Deribe ; M. S. Lawrence ; A. Protopopov ; E. Ivanova ; I. R. Watson ; E. Nickerson ; P. Ghosh ; H. Zhang ; R. Zeid ; X. Ren ; K. Cibulskis ; A. Y. Sivachenko ; N. Wagle ; A. Sucker ; C. Sougnez ; R. Onofrio ; L. Ambrogio ; D. Auclair ; T. Fennell ; S. L. Carter ; Y. Drier ; P. Stojanov ; M. A. Singer ; D. Voet ; R. Jing ; G. Saksena ; J. Barretina ; A. H. Ramos ; T. J. Pugh ; N. Stransky ; M. Parkin ; W. Winckler ; S. Mahan ; K. Ardlie ; J. Baldwin ; J. Wargo ; D. Schadendorf ; M. Meyerson ; S. B. Gabriel ; T. R. Golub ; S. N. Wagner ; E. S. Lander ; G. Getz ; L. Chin ; L. A. Garraway
Nature Publishing Group (NPG)
Published 2012Staff ViewPublication Date: 2012-05-25Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: Chromosome Breakpoints/radiation effects ; DNA Damage ; DNA Mutational Analysis ; Gene Expression Regulation, Neoplastic ; Genome, Human/*genetics ; Guanine Nucleotide Exchange Factors/*genetics/metabolism ; Humans ; Melanocytes/metabolism/pathology ; Melanoma/*genetics/pathology ; Mutagenesis/radiation effects ; Mutation/*genetics/radiation effects ; Oncogenes/genetics ; Sunlight/*adverse effects ; Ultraviolet Rays/adverse effectsPublished by: -
6T. Bald ; T. Quast ; J. Landsberg ; M. Rogava ; N. Glodde ; D. Lopez-Ramos ; J. Kohlmeyer ; S. Riesenberg ; D. van den Boorn-Konijnenberg ; C. Homig-Holzel ; R. Reuten ; B. Schadow ; H. Weighardt ; D. Wenzel ; I. Helfrich ; D. Schadendorf ; W. Bloch ; M. E. Bianchi ; C. Lugassy ; R. L. Barnhill ; M. Koch ; B. K. Fleischmann ; I. Forster ; W. Kastenmuller ; W. Kolanus ; M. Holzel ; E. Gaffal ; T. Tuting
Nature Publishing Group (NPG)
Published 2014Staff ViewPublication Date: 2014-02-28Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: Animals ; Cell Movement/radiation effects ; Cell Transformation, Neoplastic/radiation effects ; Disease Models, Animal ; Disease Progression ; Female ; HMGB1 Protein/metabolism ; Immunity, Innate/radiation effects ; Inflammation/*etiology ; Keratinocytes/metabolism/pathology/radiation effects ; Lung Neoplasms/blood supply/etiology/*secondary ; Male ; Melanocytes/pathology/radiation effects ; Melanoma/*blood supply/etiology/*pathology ; Mice ; Mice, Inbred C57BL ; Neovascularization, Pathologic/etiology ; Neutrophils/immunology/metabolism ; Skin Neoplasms/blood supply/etiology/*pathology ; Sunburn/complications/*etiology ; Toll-Like Receptor 4/metabolism ; *Ultraviolet RaysPublished by: -
7A. Kaur ; M. R. Webster ; K. Marchbank ; R. Behera ; A. Ndoye ; C. H. Kugel, 3rd ; V. M. Dang ; J. Appleton ; M. P. O'Connell ; P. Cheng ; A. A. Valiga ; R. Morissette ; N. B. McDonnell ; L. Ferrucci ; A. V. Kossenkov ; K. Meeth ; H. Y. Tang ; X. Yin ; W. H. Wood, 3rd ; E. Lehrmann ; K. G. Becker ; K. T. Flaherty ; D. T. Frederick ; J. A. Wargo ; Z. A. Cooper ; M. T. Tetzlaff ; C. Hudgens ; K. M. Aird ; R. Zhang ; X. Xu ; Q. Liu ; E. Bartlett ; G. Karakousis ; Z. Eroglu ; R. S. Lo ; M. Chan ; A. M. Menzies ; G. V. Long ; D. B. Johnson ; J. Sosman ; B. Schilling ; D. Schadendorf ; D. W. Speicher ; M. Bosenberg ; A. Ribas ; A. T. Weeraratna
Nature Publishing Group (NPG)
Published 2016Staff ViewPublication Date: 2016-04-05Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: Adult ; Aging/*metabolism ; Animals ; Cell Line, Tumor ; Culture Media, Conditioned/pharmacology ; DNA Damage ; DNA-(Apurinic or Apyrimidinic Site) Lyase/metabolism ; Disease Progression ; *Drug Resistance, Neoplasm ; Fibroblasts/secretion ; Humans ; Indoles/pharmacology/therapeutic use ; Male ; Melanoma/blood supply/*drug therapy/genetics/*pathology ; Membrane Proteins/*metabolism/secretion ; Mice ; Microphthalmia-Associated Transcription Factor/metabolism ; Middle Aged ; Molecular Targeted Therapy ; *Neoplasm Metastasis ; Neovascularization, Pathologic ; Oxidative Stress ; Phenotype ; Reactive Oxygen Species/metabolism ; Sulfonamides/pharmacology/therapeutic use ; *Tumor Microenvironment ; Wnt Signaling Pathway ; Wnt1 Protein/antagonists & inhibitors ; beta Catenin/metabolismPublished by: -
8Brinker, T. J., Faria, B. L., Gatzka, M., de Faria, O. M., Heppt, M. V., Kirchberger, M. C., Schadendorf, D., Nakamura, Y., Buslaff, F., Lisboa, O. C., Oliveira, A. C. C., Lino, H. A., Bernardes-Souza, B.
BMJ Publishing
Published 2018Staff ViewPublication Date: 2018-03-06Publisher: BMJ PublishingElectronic ISSN: 2044-6055Topics: MedicineKeywords: Open access, Dermatology, Dermatology, EpidemiologyPublished by: -
9Bezrookove, V., Nosrati, M., Miller, J. R., De Semir, D., Dar, A. A., Vosoughi, E., Vaquero, E., Sucker, A., Lazar, A. J., Gershenwald, J. E., Davies, M. A., Schadendorf, D., Kashani-Sabet, M.
The American Association for Cancer Research (AACR)
Published 2018Staff ViewPublication Date: 2018-09-05Publisher: The American Association for Cancer Research (AACR)Print ISSN: 1078-0432Electronic ISSN: 1557-3265Topics: MedicinePublished by: -
10Kugel, C. H., Douglass, S. M., Webster, M. R., Kaur, A., Liu, Q., Yin, X., Weiss, S. A., Darvishian, F., Al-Rohil, R. N., Ndoye, A., Behera, R., Alicea, G. M., Ecker, B. L., Fane, M., Allegrezza, M. J., Svoronos, N., Kumar, V., Wang, D. Y., Somasundaram, R., Hu-Lieskovan, S., Ozgun, A., Herlyn, M., Conejo-Garcia, J. R., Gabrilovich, D., Stone, E. L., Nowicki, T. S., Sosman, J., Rai, R., Carlino, M. S., Long, G. V., Marais, R., Ribas, A., Eroglu, Z., Davies, M. A., Schilling, B., Schadendorf, D., Xu, W., Amaravadi, R. K., Menzies, A. M., McQuade, J. L., Johnson, D. B., Osman, I., Weeraratna, A. T.
The American Association for Cancer Research (AACR)
Published 2018Staff ViewPublication Date: 2018-11-02Publisher: The American Association for Cancer Research (AACR)Print ISSN: 1078-0432Electronic ISSN: 1557-3265Topics: MedicinePublished by: -
11Griewank, K. G., Koelsche, C., van de Nes, J. A. P., Schrimpf, D., Gessi, M., Möller, I., Sucker, A., Scolyer, R. A., Buckland, M. E., Murali, R., Pietsch, T., von Deimling, A., Schadendorf, D.
The American Association for Cancer Research (AACR)
Published 2018Staff ViewPublication Date: 2018-09-15Publisher: The American Association for Cancer Research (AACR)Print ISSN: 1078-0432Electronic ISSN: 1557-3265Topics: MedicinePublished by: -
12Djukanovic, D ; Hofmann, U ; Sucker, A ; Schadendorf, D
Oxford, UK : Blackwell Science, Ltd
Published 2001Staff ViewISSN: 1365-2133Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineType of Medium: Electronic ResourceURL: -
13Garbea, A. ; Dippel, E. ; Hildenbrand, R. ; Bleyl, U. ; Schadendorf, D. ; Goerdt, S.
Oxford, UK : Blackwell Science, Ltd
Published 2002Staff ViewISSN: 1365-2133Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: We report on a 74-year-old female patient with a primary cutaneous CD20+, diffuse large cell B-cell lymphoma of the lower leg resembling a chronic non-healing leg ulcer. There was no evidence of systemic involvement on computed tomography (CT) scans of the chest, abdomen and pelvis; a slightly enlarged lymph node in the right groin showed dermatopathic lymphadenopathy on histology and immunohistochemistry. Involvement of the bone marrow and peripheral blood was ruled out by punch biopsy and fluorescent activated cell sorter (FACS) analysis of the blood, respectively. Therapeutic anti-CD20 monoclonal antibody rituximab was given at 375 mg m−2 i.v. once weekly for 7 weeks, without adverse effects, resulting in a minor improvement in the centre of the ulcerated tumour. Unfortunately, the response was not maintained, and after 7 weeks of treatment the patient started to develop new tumour lesions at the border of the ulcer. Local radiotherapy was started and combined photon and electron beam irradiation induced complete remission of the B-cell lymphoma.Type of Medium: Electronic ResourceURL: -
14Algermissen, B. ; Bauer, F. ; Schadendorf, D. ; Kropp, J.-D. ; Czarnetzki, B. M.
Oxford, UK : Blackwell Publishing Ltd
Published 1994Staff ViewISSN: 1600-0625Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: Abstract In order to gain insights into the dynamics of mast cell subpopulations in normal and diseased skin, a novel enzyme-histochemical double and triple staining method was employed that allowed the detection of metachromasia (toluidine blue) and the mast cell proteases tryp-tase and chymase within the same cell. Cryostat sections were used of skin biopsies from the following specimens: normal skin (N=4), psoriasis (N=13), atopic eczema (N=7), lichen planus (N=6), interferon α2a injection sites (N=l) of a leukemic infiltrate and corresponding normal skin of the same patient before and after treatment. (i) Equal numbers of tryptase-and chymase-positive mast cells (MCTC) were obtained in all normal and diseased specimens in papillary and reticular dermis, with threefold increases around appendages, (ii) Tryptase-positive mast cells (MCT) were absent in normal skin, but were markedly increased in a disease-specific pattern within the papillary dermis, the inflammatory infiltrate and around appendages, (iii) Marked increases of MCT were also noted at interferon injection sites within the leukemic infiltrate, but not in the normal skin of the same patient. These data suggest that disease-dependent mast cell dynamics involve only MCT in cutaneous inflammation and that MCT numbers are controlled by distinct, disease-specific local tissue factors.Type of Medium: Electronic ResourceURL: -
15Sun, Y. ; Song, M. ; Maeurer, M. J. ; Schadendorf, D.
Oxford, UK : Blackwell Science Ltd
Published 2001Staff ViewISSN: 1365-3083Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: In this study we have analyzed CD30-antigen expression in three melanoma-directed cytotoxic T lymphocyte (CTL) clones with a T helper 0 (Th0)-like cytokine secretion profile (i.e. interleukin (IL)-4, IL-5, and interferon (IFN)-γ). We show that all CTL clones expressed high levels of CD30 upon contact with the autologous tumour cells. One CTL clone, termed A2 with a monoclonal feature was selected for further analyses and found its CD30 expression dependent on the presence of IL-4. Functionally, a CD30-expressing A2 CTL was capable of producing higher amounts of IFN-γ (up to 1.5-fold) and IL-4 (up to two-fold) than its CD30− counterpart. Furthermore, CD30-positive A2 CTL displayed an at least three-fold greater proliferative response to the tumour cell stimulation, contrasting with CD30− CTL. However, the antitumour cytotoxic activity of A2 CTL was not modulated by the CD30 expression. These results suggest that CD30 antigen can be inducible on a subset of tumour-directed CD8+ CTL, and that this subset of cells may have profound effector functions, such as cytokine secretion, proliferation, and cytotoxicity.Type of Medium: Electronic ResourceURL: -
16SCHADENDORF, D. ; HERFORDT, R. ; CZARNETZKI, B.M.
Oxford, UK : Blackwell Publishing Ltd
Published 1995Staff ViewISSN: 1365-2133Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: Summary Metastatic malignant melanoma is notoriously resistant to chemotherapeutic agents, but the exact mechanisms involved in this drug resistance arc unknown. One recently defined major mechanism of multidrug resistance involves the overexpression of P-glycoprotein on cell membranes. In order to evaluate the significance of this putative drug efflux pump for chemoresistance of malignant melanoma, five different antibodies were employed to examine P-glycoprotein expression on tissue from 33 primary malignant melanomas and 35 metastases, before and after chemotherapy, using immunohistological techniques. The expression of P-glycoprotein was low on primary cutaneous melanomas (three of 33), and on metastases (one of 35). Normal tissue in and around the melanoma showed reactivity of endothelial cells, stromal cells and eccrine sweat glands with several antibodies tested. Chemotherapy with drugs commonly used in metastatic melanoma, including agents known to induce P-glycoprotein expression in other tumours (vindesine, cisplatin) had no effect on P-glycoprotein expression in human melanoma metastases. The high chemoresistance of human melanoma cells in vitro and in vivo is probably not mediated via P-glycoprotein, and other possible mechanisms involved will have to be explored in future studies.Type of Medium: Electronic ResourceURL: -
17Nürnberg, W ; Haas, N. ; Schadendorf, D. ; Czarnetzki, B. M.
Oxford, UK : Blackwell Publishing Ltd
Published 1995Staff ViewISSN: 1600-0625Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: Abstract It has been proposed that interleukin-6 may play a role in the pathogenesis of autoimmune diseases like lupus erythematosus. We have therefore investigated the immunoreactivity of IL-6 in 32 skin biopsies of 23 patients suffering from chronic discoid lupus erythematosus (n=16), subacute cutaneous lupus erythematosus (n=5) and systemic lupus erythematosus (n = 5) as well as in uninvolved skin (n = 6) and in normal skin from healthy volunteers (n = 3). Increased immunohistochemical staining was detectable in 14 of 26 biopsies from lesional skin. The remaining biopsies from lesional, non-lesional and normal skin displayed only minimal or no reactivity, but 8 out of 12 lupus erythematosus patients had been pretreated with local or systemic antiinflammatory drugs. Irrespective of the LE subtype, immunolabelling was generally most intense in the basal layer of the epidermis, with additional intense suprabasal staining in sections from 2 of 5 SLE patients. Preferential production of IL-6 in the lower parts of the epidermis was confirmed by RNA in situ hybridization. No correlation was found between the deposition of immuno-globulins and complement at the dermo-epidermal junction and IL-6 expression in keratinocytcs. These data suggest that IL-6 may be involved in LE although its exact role in the pathogenesis of the disease needs to be further elucidated.Type of Medium: Electronic ResourceURL: -
18Haas, N. ; Schadendorf, D. ; Henz, B.M. ; Fuchs, P.G.
Oxford, UK : Blackwell Science Ltd
Published 2002Staff ViewISSN: 1365-2133Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: Summary We describe a patient with a 9-year history of generalized eruptive keratoacanthoma (KA) of the Grzybowski type whose multiple skin lesions showed steady progression, resulting in a sclerotic, mask-like facial expression and ectropion. Eleven tumour biopsies representing lesions of different stages and localizations (erupting and regressing KAs, biopsies from non-involved light-protected and light-exposed skin, dermatosclerosis and squamous cell carcinomas) were analysed for human papillomavirus (HPV) sequences using a polymerase chain reaction approach capable of detecting the majority of all presently known HPV genotypes. None of the biopsy specimens proved to be HPV-positive, although HPV was detected in weakly and heavily affected control specimens by the method applied. These findings suggest an HPV-independent aetiology of this rare type of multiple KA.Type of Medium: Electronic ResourceURL: -
19DIPPEL, E. ; HAAS, N. ; GRABBE, J. ; SCHADENDORF, D. ; HAMANN, K. ; CZARNETZKI, B.M.
Oxford, UK : Blackwell Publishing Ltd
Published 1995Staff ViewISSN: 1365-2133Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: In order to investigate possible alterations in c-kit protein expression on epidermal melanocytes in different hypopigmentary disorders, we have examined skin specimens from one patient with piebaldism, one patient with naevus depigmentosus, and five patients with vitiligo. Cryosections were examined by immunohistochemistry using monoclonal antibodies against the c-kit protein (YB5.B8) and melanosomes (TA99).In piebaldism, hypomelanotic epidermis contained only a few TA99-positive epidermal melanocytes and no detectable c-kit protein, whereas in naevus depigmentosus the expression of c-kit protein was strong, and TA99 immunoreactivity was faint. In vitiligo lesions, no epidermal immunoreactivity for melanosomes or c-kit protein was found. Normally pigmented skin of all patients showed immunoreactivity of epidermal melanocytes for both c-kit protein and melanosomes.Different hypomelanotic lesions can thus be differentiated by absent melanocyte c-kit protein and low or no expression of melanosomal marker in piebaldism, normal c-kit but low melanosome expression in naevus depigmentosus, and the absence of all melanocyte markers in vitiligo.Type of Medium: Electronic ResourceURL: -
20Usener, D. ; Gerhardt, A. ; Schadendorf, D. ; Eichmüller, S.
Oxford, UK : Blackwell Science Ltd
Published 2003Staff ViewISSN: 1365-2133Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: Summary Background Cancer-testis antigens exemplify a growing number of tumour antigens which are expressed in a variety of malignancies, but not in normal tissues other than germ cells, primarily those of the testis. Objectives To investigate the humoral response to known cancer-testis antigens in melanoma patients. Methods We used phage clones coding for seven different melanoma antigens MAGE-A or LAGE-1A proteins. These clones were isolated using the newly developed DNA hybridization analysis of recombinantly expressed cDNA libraries (HYREX) approach. HYREX combines the advantage of a nonradioactive library screening method with the possibility of subsequently analysing the serological response to the recombinant proteins. We isolated clones coding for MAGE-A1, -A3, -A4b, -A6, -A9 and -A12, as well as LAGE-1A. Additionally, we correlated gene expression and seroreactivity. Results Between 13% and 27% of sera (n = 15) were reactive against individual tumour antigens. We found the presence of specific antibodies was, with only two exceptions, generally correlated with mRNA expression of the antigen within cell lines derived from the same patient. While cross-reactivity of patients' IgG might play a role in these cases, antibodies from patients' sera were able to distinguish even the closely related MAGE-A3 and -A6. In general, the mRNA expression frequency was higher than the detected IgG responses. Conclusions Antibody recognition of specific tumour antigens by patients' sera may be used for evaluating the possible immunogenicity of new antigens; serological tests could be used for tumour monitoring purposes.Type of Medium: Electronic ResourceURL: